20+ Years of Evidence

Join the experts’ corner

This page presents publications and webinars from around the globe. It includes evidence for a wide range of treatment sites including malignant and benign disease, different fractionation schedules and motion synchronization techniques for both the CyberKnife® and TomoTherapy® platforms. We update new papers on a regular basis. Please take a moment to explore the page and see the evidence we have collected to truly demonstrate how we are making a change to peoples’ lives.

Featured Content

Pancreatic Cancer Awareness

Use of Nab-Paclitaxel Plus Gemcitabine Followed by Hypofractionated Tomotherapy With Simultaneous Integrated Boost in Patients With Locally Advanced Pancreatic Cancer

Date: 2022
Treatment Technique: Hypofractionation with SIB
Platform: TomoTherapy
Author: Zhan Shi et al.

Lung Cancer Awareness

High-dose stereotactic body radiotherapy using CyberKnife® for stage I peripheral lung cancer: a single-center retrospective study

Date: 2022
Treatment Technique: High-dose SBRT
Platform: CyberKnife
Author: Yasuhiro Ryuno et al.

Movember

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial

Date: 2022
Treatment Technique: Ultra-hypofractionation
Platform: CyberKnife
Author: Alison Tree et al.
  • Products

  • Techniques

  • Types

  • Indications

  • Event

  • Formats

  • Products

  • Techniques

  • Types

  • Indications